Short Interest in EOM Pharmaceuticals Holdings, Inc. (OTCMKTS:IMUC) Declines By 14.3%

EOM Pharmaceuticals Holdings, Inc. (OTCMKTS:IMUC) was the target of a significant decline in short interest during the month of July. As of July 31st, there was short interest totalling 600 shares, a decline of 14.3% from the July 15th total of 700 shares. Based on an average trading volume of 2,900 shares, the days-to-cover ratio is currently 0.2 days.

EOM Pharmaceuticals Trading Up 29.1 %

Shares of IMUC stock opened at $0.15 on Monday. The company has a fifty day moving average price of $0.16 and a two-hundred day moving average price of $0.20. EOM Pharmaceuticals has a one year low of $0.07 and a one year high of $0.40.

EOM Pharmaceuticals Company Profile

Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis.